Company Filing History:
Years Active: 1986-1994
Title: David S Kaplan: Innovator in Biomedical Engineering
Introduction
David S Kaplan is a notable inventor based in Fairfax Station, VA (US). He has made significant contributions to the field of biomedical engineering, holding a total of 3 patents. His work primarily focuses on the interactions between biological cells and biomaterials, which is crucial for the development of medical devices.
Latest Patents
One of Kaplan's latest patents is a method for real-time monitoring of oxidative products from in vitro cell-biomaterial interactions. This chemiluminescence method allows for continuous monitoring of oxidative products such as hydrogen peroxide and superoxide. It utilizes various cell lines, including Human Leukemic cells, tumor cell line hybridomas, and primary human cells. This innovation aids in predicting the functional lifetime of biomaterials used in implanted medical devices by assessing the degradation potential and the inflammatory response.
Another significant patent is a device for quantitative endpoint determination in immunofluorescence. This invention provides a process for quantifying Toxoplasma gondii and Treponema pallidum antibody titers in biological samples through immunofluorescent photometric microscopy. This advancement enhances the accuracy of immunological assessments.
Career Highlights
Throughout his career, David S Kaplan has worked with esteemed organizations, including the United States of America as represented by the Secretary of Health and the Department of Health. His expertise in biomedical engineering has positioned him as a key figure in the development of innovative medical technologies.
Collaborations
Kaplan has collaborated with notable professionals in his field, including Grace L Picciolo and Edward P Mueller. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
David S Kaplan's contributions to biomedical engineering through his innovative patents demonstrate his commitment to improving medical technology. His work not only enhances our understanding of cell-biomaterial interactions but also paves the way for safer and more effective medical devices.